We have reported that streptozotocin-induced insulin-dependent diabete
s mellitus in 25% reduced renal mass rats is associated with low-renin
, volume-expanded hypertension and that the development of the hyperte
nsion can be prevented with insulin. In this study we examined the eff
ect of insulin after the animals had developed sustained hypertension.
Normotensive 25% reduced renal mass rats were treated with streptozot
ocin and, as expected, developed insulin-dependent diabetes mellitus a
nd hypertension. After 4 weeks of sustained hypertension, neutral prot
amine Hagedorn insulin (6 to 8 IU/d) was administered subcutaneously f
or 4 weeks. As expected, insulin treatment decreased plasma glucose an
d increased body weight gain relative to untreated diabetic rats. On t
he other hand, insulin treatment did not reverse the hypertension and
albuminuria. It also did not normalize extracellular fluid volume and
plasma renin activity. Furthermore, insulin treatment did not reverse
the increase in plasma Na+,K+-ATPase inhibitory activity (determined b
y both radioimmunoassay and bioassay) and the inhibition of myocardial
microsomal Na+,K+-ATPase activity observed in the untreated diabetic
hypertensive rats. 5'-Nucleotidase, a membrane marker, was not differe
nt between insulin-treated and untreated diabetic rats. These results
show that insulin, given as here described, does not reverse the insul
in-dependent diabetes mellitus hypertension in 25% reduced renal mass
rats once it is established, perhaps because it does not reverse the a
lbuminuria, volume expansion, increase in endogenous digitalis-like su
bstance, and inhibition of cardiovascular muscle cell Na+,K+-ATPase ac
tivity.